Condition: Ischemic Stroke · Transient Ischemic Attack · Sponsor: Mazandaran University of Medical Sciences
This is a randomized, controlled, outcome assessor blind, parallel group design pilot study on 100 patient with diagnosis of ischemic stroke admitted in Bou-Ali Sina Hospital, Sari,Iran.The aim of study is to compare the efficacy of 90 mg ticagrelor BID plus aspirin for 1 month and 60 mg ticagrelor BID plus aspirin for 6 months in reduce of non-disabling non-cardioembolic ischemic stroke or high risk TIA recurrence during first 12 months.
This description comes directly from the study's public registry record.
Athena Sharifi Razavi, MD · +989113510136 · athena.sharifi@yahoo.com
Nasim Tabrizi, MD · 00989111263538 · nasimtabrizi@gmail.com
Always discuss trial participation with your own doctor first.
| Mazandaran province, Sari,Iran | Sari, Mazandaran, Iran | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06653348